86 related articles for article (PubMed ID: 2371973)
1. Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling.
Deshmukh P; Ramsey L; Garewal HS
Am J Clin Pathol; 1990 Aug; 94(2):192-5. PubMed ID: 2371973
[TBL] [Abstract][Full Text] [Related]
2. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
Kamel OW; Franklin WA; Ringus JC; Meyer JS
Am J Pathol; 1989 Jan; 134(1):107-13. PubMed ID: 2536520
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.
Yonemura Y; Kimura H; Ooyama S; Kamata T; Yamaguchi A; Matsumoto H; Ninomiya I; Miyazaki I
Oncology; 1991; 48(2):162-5. PubMed ID: 1997941
[TBL] [Abstract][Full Text] [Related]
4. Assessment of tumor cell kinetics by monoclonal antibody Ki-67.
Yonemura Y; Ohoyama S; Kimura H; Kamata T; Yamaguchi A; Miyazaki I
Eur Surg Res; 1990; 22(6):365-70. PubMed ID: 2079097
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the thymidine labeling and Ki-67 proliferative indices in 126 breast cancer patients.
Molino A; Pedersini R; Micciolo R; Frisinghelli M; Giovannini M; Pavarana M; Nortilli R; Santo A; Manno P; Padovani M; Piubello Q; Cetto GL
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):304-9. PubMed ID: 12607597
[TBL] [Abstract][Full Text] [Related]
6. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
Kunz J
Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
[TBL] [Abstract][Full Text] [Related]
7. Significance of the Tritiated Thymidine Labeling Index in breast cancers.
Araki K; Kimura M; Sakamoto K; Nishimura R; Akagi M
Jpn J Surg; 1985 Mar; 15(2):144-9. PubMed ID: 4010096
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical demonstration of DNA polymerase alpha in human brain-tumor cells.
Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Matsumi N; Satoh T; Matsumoto K; Furuta T; Nishimoto A; Shiraishi T
J Neurosurg; 1990 Feb; 72(2):268-72. PubMed ID: 1967302
[TBL] [Abstract][Full Text] [Related]
9. Variability of the thymidine labeling index in squamous cell carcinoma of the head and neck.
Greenberg B; Woo L; Blatchford S; Aguirre M; Garewal H
Laryngoscope; 1988 Jun; 98(6 Pt 1):668-70. PubMed ID: 3374244
[TBL] [Abstract][Full Text] [Related]
10. Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase.
Alama A; Conte PF; Di Marco E; Favoni RE; Nicolin A
Oncology; 1986; 43(6):385-9. PubMed ID: 3808572
[TBL] [Abstract][Full Text] [Related]
11. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.
Meyer JS; Coplin MD
Am J Clin Pathol; 1988 May; 89(5):586-95. PubMed ID: 3358366
[TBL] [Abstract][Full Text] [Related]
12. Measures of tumor proliferative activity.
Brooks DJ; Garewal HS
Int J Clin Lab Res; 1992; 22(4):196-200. PubMed ID: 1361373
[TBL] [Abstract][Full Text] [Related]
13. Reliability of 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers.
Ponz de Leon M; Costa A; Lanza G; Scalmati A; Roncucci L; Faranda A; Di Gregorio C; Fante R; Colella G; Silvestrini R
Mod Pathol; 1991 Sep; 4(5):627-31. PubMed ID: 1758875
[TBL] [Abstract][Full Text] [Related]
14. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody. A quantitative immunohistochemical study.
Smolle J; Soyer HP; Kerl H
Am J Dermatopathol; 1989 Aug; 11(4):301-7. PubMed ID: 2774099
[TBL] [Abstract][Full Text] [Related]
16. Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features.
Veronese SM; Gambacorta M
Am J Clin Pathol; 1991 Jan; 95(1):30-4. PubMed ID: 1987749
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody Ki-67: its use in histopathology.
Brown DC; Gatter KC
Histopathology; 1990 Dec; 17(6):489-503. PubMed ID: 2076881
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
